Platelet Aggregation Devices Market is projected to be worth USD 2284.51 million at CAGR of 21.50% during the forecast period 2020-2030.
Platelet Aggregation Devices Market Overview
The global platelet aggregation devices market is projected to account for USD 2284.51 million by the end of the year 2030. Further, this global market is estimated to expand at a CAGR of 21.50% during the research period. In platelet aggregation, the platelets are clumped within the blood, which results in the formation of a thrombus or a clot.
The worldwide Platelet Aggregation Devices Market growth is driven due to several important factors such as the increasing prevalence of target diseases, rising older population, increasing technological development in relation to platelet aggregators, and increasing number of clinical studies and industry-academia collaborations. According to the World Health Organization (WHO) report, the global population aged 60 years and above is increasing. In 2017, it was 962.0 million, and it is estimated to increase to more than 2.0 billion by the end of the year 2050. Further, the global population aged 60 years and above is expected to reach 3.1 billion by the end of the year 2100. The rising global old age population is projected to fuel the growth of the global market for Platelet Aggregation Devices in the forecast timeframe.
However, the global market for Platelet Aggregation Devices might face restraints due to the procedural limitations and existing unfavourable healthcare reforms in the US during the assessment period.
The global platelet aggregation devices market has been segmented into product, application, and end user.
By product, the market has been segmented into systems, reagents, and consumables and accessories. In 2017, the systems segment dominated the market due to continuous technological advancements in sensors and detectors, increasing automation of platelet aggregation testing procedures, and growing adoption and market preference for automated instruments among diagnostic laboratories
On the basis of application, the market has been divided into clinical applications and research applications. The clinical applications segment is further divided into cardiovascular applications, orthopedic applications, and others.
Based on end user, the market has been categorized into hospitals and clinics, diagnostic laboratories, research and academic institutes, and others.
The global platelet aggregation devices market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The platelet aggregation devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European platelet aggregation devices market has been segmented into Western Europe and Eastern Europe. The Western Europe platelet aggregation devices market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The platelet aggregation devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The platelet aggregation devices market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Geographically, in 2017, the Americas led the global platelet aggregation devices market due to the presence of device manufacturers, surging number of surgical procedures, growing awareness among healthcare professionals (HCPs) about the benefits offered by platelet aggregation testing in disease diagnosis, and significant investments in R&D activities which utilize platelets. For instance, according to the National Center for Health Statistics, in 2009, about 48.0 million surgical inpatient procedures were performed in the US, which grew to 1.54 million in the year end 2017.
The availability of affordable platelet function tests and expanding distribution channels, surging number of cardiovascular surgeries, new technological developments in platelet aggregators, and increase in number of clinical studies in the UK, Germany, and France is expected to support the second largest position of Europe in the global market. For instance, as per the data published by the European Medicines Agency (EMA) and the British Medical Journal, approximately 4,000 clinical trials of medicines are authorized annually in the European Union (EU).
The market in Asia-Pacific would witness the fastest growth during the forecast period attributed to growing geriatric population coupled with rising prevalence of chronic diseases, increasing adoption of new technological devices, and rising incidences of mosquito-borne diseases, namely, malaria and dengue. According to the World Health Organization, severe dengue is a leading cause of serious illness and death among children in some Asian and Latin American countries. More than 40.0% of the world’s population in more than 100 countries are at risk of dengue infection. The most significant dengue epidemics in recent years have occurred in Southeast Asia, the Americas and the Western Pacific. An estimated 390.0 million dengue infections occur across the globe every year.
The platelet aggregation devices market in the Middle East & Africa would register the modest market growth rate from 2018 to 2023 owing to adoption of novel technologies, rising prevalence of hemophilia disease, improving healthcare infrastructure, and expansion of business by various market players in Gulf Cooperation Council (GCC) countries, Israel, and South Africa.
Global Platelet Aggregation Devices Market, by Product
Global Platelet Aggregation Devices Market, by Application
Global Platelet Aggregation Devices Market, by End User
Global Platelet Aggregation Devices Market, by Region
Global Platelet Aggregation Devices Market, by Key Players
In July 2021, two new automated blood coagulation analyzers were launched by the prominent market player Sysmex Corporation in the EMEA region, i.e., CN-6500 and CN-3500. These new blood coagulation analyzers have been developed with an aim to provide flexible measurements to the wide range of test orders in the hemostasis and thrombosis field. It has also ensured that CN-6000 or CN-3000 measures the platelet aggregation parameters and the blood coagulation.Intended Audience
|Market Size||2030: USD 2284.51 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product, Application and End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Siemens Healthineers, Hoffmann-La Roche Ltd, Sentinel CH. SpA, Sysmex Corporation, Werfen, Helena Laboratories, Bio/Data Corporation, Haemonetics Corporation, AggreDyne, Haemochrom Diagnostica GmbH, Pathway Diagnostics Limited,|
|Key Market Opportunities||Healthcare infrastructure, and expansion of business|
|Key Market Drivers||The rising prevalence of hematological diseases is the major driver for the market.|
The platelet aggregation devices market was valued at USD 2284.5 million in 2030.
The global platelet aggregation devices market is expected to exhibit a strong 21.50% CAGR over the forecast period from 2020 to 2030.
The rising prevalence of hematological diseases is the major driver for the market.
The Americas dominate the global platelet aggregation devices market.
Leading players in the market include Siemens, Werfen, Haemonetics Corporation, AggreDyne Inc., and Sysmex, among others.